Case study: Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA™ Solution

Published: 27-Oct-2011

Paper-based processes still burden most QC micro programs with paper scheduling, lab marker labeling of sample media, manual reconciliation, paper log book entry, and manual notification on deviations. These steps are labor-intensive, time consuming, and yield duplication of tasks and high error rates. Amylin, a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines, has successfully implemented MODA™—a paperless QC Micro solution by Lonza. As a result, Amylin is achieving their goal to automate their QC processes and regulatory compliance at their manufacturing facility.


Featured speaker
Dominick Villani, Manager of QC Microbiology, Amylin Pharmaceuticals

Focus areas
• Industry best practices, strategies, and regulatory guidelines
• Definitions of qualification, re-qualification and routine monitoring
• Use of automation and the MODA™ solution to meet requirements
• Tracking, trending, and report generation compliance using MODA™ solution

Click here to download the webinar PDF presentation and video recording (From June 7, 2011)
*Note: Log in is required to access Lonza’s webinar archives. If you do not have a Lonza account, sign up by filing out a short form. This account will also give you access to Lonza’s comprehensive Cell Transfection Database.

  • Companies:
  • Lonza
See more

You may also like

Cleaning

Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems

Read more
Lonza has launched PyroCell MAT Rapid System and PyroCellMAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit

Trending Articles

  1. Procurement and sustainability lead for cleanroom firm KeyPlants talks balancing these concepts Christian Krona, the Head of Procurement and Sustainability at the Sweden-based design and construction firm discusses implementing sustainability into procurement, the availability of fossil-free steel and concrete, and the future of the construction industry
  2. Legionella testing: Modern alternatives to the ‘gold standard’ test The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have their downsides. Jeff Bates from IDEXX explains
  3. Facility design expert AM Technical Solutions supports "chip hub" potential of India AM Technical Solutions is supporting key players in the Indian semiconductor market to aid them in establishing manufacturing facilities in the country
  4. Gloveless or less gloves: Reframing the “hands-off” cleanroom isolator debate As fill-finish automation continues to make exciting progress, the question of how best to implement automated solutions in an isolator setting continues to be raised, specifically as it relates to gloved vs gloveless applications. Josh Russell from AST discusses
  5. MSA Safety opens Morocco PPE manufacturing facility MSA Safety has marked the grand opening of a new Manufacturing Operations centre in Chelalate, Morocco

Upcoming event

Cleanroom Technology Conference UK

22–23 May 2024 | Conference and Exhibition | Birmingham, UK See all

You may also like

Cleaning

Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems

Lonza has launched PyroCell MAT Rapid System and PyroCellMAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Analysis

Lonza to phase out traditional endotoxin testing LAL and TAL assay reader for new tech

The company has launched the Nebula Absorbance Reader that is a technologically advanced, high-performance replacement reader, which delivers results comparable to those typically found with the traditional method and will facilitate the smooth continuation of current pyrogen and endotoxin testing programmes
Pharmaceutical

Q&A: Lonza’s PyroCell Monocyte activation test

Lonza has launched the PyroCell MAT that uses human serum instead of foetal bovine serum for pharmaceutical testing, but how does it change the status quo?
Design & Build

Lonza commissions BAM for Chemelot mRNA facility renovation

Lonza has commissioned BAM to renovate the ground floor up to and including the second floor of its Brighthouse building 300 on the Brightlands Chemelot Campus
Cleaning

Q&A on Lonza’s new PyroCell Monocyte Activation Test

Speaking to Katrin Pauls from Lonza about the launch of the company's PyroCell MAT, which uses human serum instead of foetal bovine serum for pharmaceutical testing, and how it changes the status quo
Cleaning

Lonza debuts first multimode reader to streamline quantitative endotoxin detection

The global science company has launched the Nebula Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods
Regulatory

Lonza launches non-bovine test for non-endotoxin pyrogen contaminants

Lonza has launched the PyroCell Monocyte Activation Test that uses human serum instead of fetal bovine serum for pharmaceutical testing
Subscribe now